Display options
Share it on

Evid Based Complement Alternat Med. 2016;2016:8934362. doi: 10.1155/2016/8934362. Epub 2016 Jun 15.

Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats.

Evidence-based complementary and alternative medicine : eCAM

Oluwafemi O Oguntibeju, Samantha Meyer, Yapo G Aboua, Mediline Goboza

Affiliations

  1. Nutrition & Chronic Disease Research Group, Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa.
  2. Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa.
  3. Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa.

PMID: 27403200 PMCID: PMC4925985 DOI: 10.1155/2016/8934362

Abstract

Background. Hypoxis hemerocallidea is a native plant that grows in the Southern African regions and is well known for its beneficial medicinal effects in the treatment of diabetes, cancer, and high blood pressure. Aim. This study evaluated the effects of Hypoxis hemerocallidea on oxidative stress biomarkers, hepatic injury, and other selected biomarkers in the liver and kidneys of healthy nondiabetic and streptozotocin- (STZ-) induced diabetic male Wistar rats. Materials and Methods. Rats were injected intraperitoneally with 50 mg/kg of STZ to induce diabetes. The plant extract-Hypoxis hemerocallidea (200 mg/kg or 800 mg/kg) aqueous solution was administered (daily) orally for 6 weeks. Antioxidant activities were analysed using a Multiskan Spectrum plate reader while other serum biomarkers were measured using the RANDOX chemistry analyser. Results. Both dosages (200 mg/kg and 800 mg/kg) of Hypoxis hemerocallidea significantly reduced the blood glucose levels in STZ-induced diabetic groups. Activities of liver enzymes were increased in the diabetic control and in the diabetic group treated with 800 mg/kg, whereas the 200 mg/kg dosage ameliorated hepatic injury. In the hepatic tissue, the oxygen radical absorbance capacity (ORAC), ferric reducing antioxidant power (FRAP), catalase, and total glutathione were reduced in the diabetic control group. However treatment with both doses improved the antioxidant status. The FRAP and the catalase activities in the kidney were elevated in the STZ-induced diabetic group treated with 800 mg/kg of the extract possibly due to compensatory responses. Conclusion. Hypoxis hemerocallidea demonstrated antihyperglycemic and antioxidant effects especially in the liver tissue.

References

  1. J Ethnopharmacol. 2006 Jan 3;103(1):126-34 - PubMed
  2. Exp Physiol. 2015 Sep;100(9):1052-63 - PubMed
  3. Acta Diabetol. 2010 Dec;47 Suppl 1:71-6 - PubMed
  4. Rev Diabet Stud. 2010 Spring;7(1):15-25 - PubMed
  5. Gastroenterology Res. 2010 Feb;3(1):32-38 - PubMed
  6. J Ethnopharmacol. 2015 Jan 15;159:238-44 - PubMed
  7. J Am Soc Nephrol. 2013 Feb;24(2):302-8 - PubMed
  8. Methods Find Exp Clin Pharmacol. 2003 Oct;25(8):617-23 - PubMed
  9. Phytomedicine. 2006 Nov;13(9-10):624-9 - PubMed
  10. Cell Signal. 2012 May;24(5):981-90 - PubMed
  11. Phytomedicine. 2011 Dec 15;19(1):25-31 - PubMed
  12. Br J Nutr. 2006 Oct;96(4):660-6 - PubMed
  13. Methods Enzymol. 1999;299:267-76 - PubMed
  14. Nat Clin Pract Endocrinol Metab. 2008 Aug;4(8):444-52 - PubMed
  15. Apoptosis. 2009 Dec;14(12):1451-8 - PubMed
  16. ScientificWorldJournal. 2014 Mar 24;2014:921080 - PubMed
  17. Circ Res. 2010 Oct 29;107(9):1058-70 - PubMed
  18. J Agric Food Chem. 2007 Mar 7;55(5):1707-11 - PubMed
  19. J Ethnopharmacol. 2007 Sep 25;113(3):479-86 - PubMed
  20. Asian Pac J Trop Med. 2014 Jul;7(7):536-44 - PubMed
  21. BMC Complement Altern Med. 2012 Nov 28;12:236 - PubMed
  22. J Clin Biochem Nutr. 2010 Sep;47(2):98-106 - PubMed
  23. Methods Enzymol. 2000;322:413-21 - PubMed
  24. Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S65-74 - PubMed
  25. Diabetes Res Clin Pract. 2003 Jul;61(1):69-76 - PubMed
  26. J Nutr. 2005 Oct;135(10):2299-304 - PubMed
  27. Arch Biochem Biophys. 2007 Nov 1;467(1):119-31 - PubMed
  28. Ren Fail. 2005;27(6):763-70 - PubMed
  29. Diabetes Res Clin Pract. 2011 Dec;94(3):311-21 - PubMed
  30. Vascul Pharmacol. 2013 Apr;58(4):259-71 - PubMed
  31. J Endocrinol. 2010 May;205(2):187-200 - PubMed
  32. N Am J Med Sci. 2013 Mar;5(3):213-9 - PubMed

Publication Types